← Leaderboards
Alan B Frey
New York University School Of Medicine
$3,124,558
Attributed
$3,124,558
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $300K · FY2006–10$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$3,124,558 · 3
By mechanism
R01$3,124,558 · 3
Top collaborators
No co-investigators on record.
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Michael L Dustin$32,535,535
- Steven J Burden$20,147,110
- Michelle Krogsgaard$10,631,626
- Stevan R. Hubbard$8,441,812
- Kwok Kin Wong$31,472,345
Others in their field
Top investigators on “Macrophage”
- Craig B Thompson · Sloan-Kettering Inst Can Research$41,669,179
- Howard Eliot Gendelman · Children'S Memorial Hospital (Chicago)$41,668,744
- Selwyn M Vickers · University Of Alabama At Birmingham$40,969,055
- Alan A Aderem · University Of Washington$38,969,733
- Alan Richard Tall · Columbia University Health Sciences$38,053,695
- John S Condeelis · Yeshiva University$33,855,255
Research focus
MacrophageTumor AntigensNeoplasm /Cancer ImmunologyBreast NeoplasmsWestern BlottingsAdenocarcinoma CellAnergyDesignBinding (Molecular Function)BaseBiochemicalAffectCancer PatientCancer TherapyCharacteristicsAdoptive TransferCellsAutologous Tumor-Infiltrating LymphocyteClinical ResearchCoculture TechniquesComplexCytokine ReceptorsCytoplasmic GranulesCd8b1 Gene
Grant awards (11)
Tumor-Induced Defective CTL Lytic Function$292,138
R01 · FY2010 · CA · contact PI
Tumor-Induced Defective CTL Lytic Function$292,138
R01 · FY2009 · CA · contact PI
Tumor-Induced Defective CTL Lytic Function$292,138
R01 · FY2008 · CA · contact PI
Tumor-Induced Defective CTL Lytic Function$291,276
R01 · FY2007 · CA · contact PI
Tumor-Induced Defective CTL Lytic Function$299,975
R01 · FY2006 · CA · contact PI
MECHANISM OF T CELL ANERGY INDUCED BY BREAST CANCER$282,259
R01 · FY2003 · CA
MECHANISM OF T CELL ANERGY INDUCED BY BREAST CANCER$274,040
R01 · FY2002 · CA
MECHANISM OF T CELL ANERGY INDUCED BY BREAST CANCER$266,058
R01 · FY2001 · CA
SHARED TUMOR REJECTION ANTIGENS IN BREAST CANCER$265,224
R01 · FY2001 · CA
SHARED TUMOR REJECTION ANTIGENS IN BREAST CANCER$311,003
R01 · FY2000 · CA
MECHANISM OF T CELL ANERGY INDUCED BY BREAST CANCER$258,309
R01 · FY2000 · CA